Xcout IntelYpsilon Therapeutics
Ypsilon Therapeutics is a biotechnology research company founded in 2024 and headquartered in Waltham, Massachusetts, that develops T cell receptor mimics against tumor antigens.
The full profile of Ypsilon Therapeutics
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Ypsilon Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Ypsilon Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.